Alfred E. Mann



Alfred E. Mann was our Chairman Emeritus. Mr. Mann was the Chairman of MannKind from 2001 until February 2016 and, from November 2003 until January 2015, was its Chief Executive Officer. Mr. Mann founded and largely funded 14 companies in his career. Nine were acquired at an overall total of almost $8 billion, and three companies went public. In addition to MannKind, he was involved with:



  • MiniMed (now Medtronic MiniMed), which develops, manufactures and distributes microinfusion systems and continuous glucose monitoring systems that have revolutionized the treatment of type 1 diabetes.
  • Advanced Bionics Corporation (now part of Boston Scientific Corporation), which develops neurostimulation devices for various neural deficits, including cochlear stimulators.
  • Second Sight, which is developing a visual prosthesis to restore sight to the blind.
  • Pacesetter Systems (now the Cardiac Rhythm Management unit of St. Jude Medical), which develops, manufactures and distributes cardiac pacemakers.
  • Bioness, which develops and manufactures systems to address neural deficits and to restore controlled function of paralyzed limbs.
  • IncuMed, which is developing novel percutaneous seals for various applications.
  • PerQFlo, which is developing drug delivery systems.
  • RoundTrip, which is developing location and identification technology.
  • Medical Research Group, a developer of an artificial pancreas, which was also acquired by Medtronic.
  • Spectrolab, an electro-optical and aerospace systems company, and Heliotek, a semiconductor and electro-optical components manufacturer. These companies are now part of the Boeing Company. 


Mr. Mann founded and endowed, and from 1985 until 2006 served as Chairman of the Board of Trustees of The Alfred Mann Foundation, a nonprofit research organization devoted to development of advanced medical products in a variety of fields. Mr. Mann held B.A. and M.S. degrees in physics from the University of California, Los Angeles and honorary doctorate degrees from the University of Southern California, The Johns Hopkins University, Western University and the Technion Institute (Israel). Mr. Mann was also a member of the National Academy of Engineering.

For nearly six decades, Alfred Mann was a revolutionary voice and thinker in aerospace, medical technology and biopharmaceuticals and has led the development of many products to fill unmet and poorly met medical needs.


If you are reporting an Adverse Event and/or device complaint, please contact MannKind Medical Information at 1-877-323-8505 or Do not use this form for adverse events and/or device complaints.